Received: 3 January 2019
Accepted: 19 June 2019
First Online: 3 July 2019
Ethics approval and consent to participate
: This study was approved by the Severance Hospital Institutional Review Board.(4–2018-0556). Written consents were obtained from all patients tested for NGS of a hereditary cancer panel.
: Not Applicable.
: The authors declare that they have no competing interests.